TACE reduces the percentage of myeloid-derived suppressor cell in peripheral blood of HBV-related primary liver cancer patients

TACE reduces the percentage of myeloid-derived suppressor cell in peripheral blood of HBV-related primary liver cancer patients

SHAO Ming-liang, ZHANG Wei, MIAO Tong-guo, et al

PDF(1066 KB)

Welcome to Current Immunology, Today is

PDF(1066 KB)

Current Immunology ›› 2021, Vol. 41 ›› Issue (4) : 313-319.

TACE reduces the percentage of myeloid-derived suppressor cell in peripheral blood of HBV-related primary liver cancer patients

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 41(4): 313-319

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1066 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉